Paraxanthine

Eugeroic / Ergogenic

Stimulation, focus and performance support

Reading this compound Reference only

Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.

Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.

Mechanism & Use

Compound type: Methylxanthine
Primary mechanism: Adenosine receptor antagonism
Primary market use: Energy/performance

Pharmacology

Molecular weight (Da): 180.2
Oral bioavailability: High
Half-life: ~3-6 h
Route tags: Oral
Evidence level: Human/supplement
Clinical status: Supplement/research
Value-for-money score: 7 / 10

Reported protocol signal

No popular protocol verified yet; keep as reference compound until protocol signal is added.

For orientation only. See disclaimer — always consult a licensed clinician before use.

Notes

Transient stimulant effect

Sources

https://pubmed.ncbi.nlm.nih.gov/